liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
The increased risk for thromboembolism pre-cystectomy in patients undergoing neoadjuvant chemotherapy for muscle-invasive urinary bladder cancer is mainly due to central venous access: a multicenter evaluation
Umea Univ, Sweden.
Linköping University, Department of Clinical and Experimental Medicine. Linköping University, Faculty of Medicine and Health Sciences. Region Östergötland, Center for Surgery, Orthopaedics and Cancer Treatment, Department of Urology in Östergötland.
Umea Univ, Sweden; Sundsvall Hosp, Sweden.
Linköping University, Department of Clinical and Experimental Medicine. Linköping University, Faculty of Medicine and Health Sciences. Region Östergötland, Center for Surgery, Orthopaedics and Cancer Treatment, Department of Urology in Östergötland.
Show others and affiliations
2020 (English)In: International Urology and Nephrology, ISSN 0301-1623, E-ISSN 1573-2584, Vol. 52, p. 661-669Article in journal (Refereed) Published
Abstract [en]

Purpose To investigate if patients receiving neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (MIBC) had an increased risk of thromboembolic events (TEE) and to evaluate when these events occur on a timeline starting from 6 months pre-cystectomy, during NAC-administration and 60 months post-cystectomy. Methods Two hundred and fifty five patients undergoing radical cystectomy during 2009-2014 at three Swedish cystectomy centers (Umea, Linkoping and Sundsvall) were in-detail reviewed retrospectively, using individual medical records. One hundred and twenty nine patients were ineligible for analysis. NAC patients (n = 67) were compared to NAC-naive NAC-eligible patients (n = 59). The occurrence of TEE was divided into different periods pre-cystectomy and post-cystectomy. Statistical analyses included Chi-squared and logistical regression tests. Results Significant associations were found between receiving NAC and acquiring a TEE during NAC therapy pre-cystectomy. All but one pre-cystectomy event was venous and all but one of the patients received NAC. 31% (14/45) of TEEs occurred pre-cystectomy. The incidence of TEEs pre-cystectomy in NAC-naive NAC-eligible patients was only 10% (2/20), whereas the incidence of TEEs in NAC patients occurred pre-cystectomy in 48% (12/25) and 11/12 incidents were detected during NAC therapy-this including 7/11 (64%) incidents affecting veins in anatomical conjunction with the placement of central venous access for chemotherapy administration. Conclusions There is a significantly increased risk for TEE pre-cystectomy during chemotherapy administration in MIBC patients receiving NAC, compared to the risk in NAC-naive NAC-eligible MIBC patients. In 64% of the pre-RC TEEs in NAC patients, there was a clinical connection to placement of central venous access.

Place, publisher, year, edition, pages
SPRINGER , 2020. Vol. 52, p. 661-669
Keywords [en]
Complications; Cystectomy; Neoadjuvant therapy; Thromboembolism; Urinary bladder neoplasms
National Category
Urology and Nephrology
Identifiers
URN: urn:nbn:se:liu:diva-162510DOI: 10.1007/s11255-019-02338-4ISI: 000497189400001PubMedID: 31745708OAI: oai:DiVA.org:liu-162510DiVA, id: diva2:1378759
Note

Funding Agencies|Umea University; Swedish Research Council funding for clinical research in medicine (ALF) in Vasterbotten, VLL, Sweden [Bas-ALF/VLL RV-848051]; Cancer Research Foundation in Norrland, Umea, Sweden [CFF LP 13-2000]

Available from: 2019-12-13 Created: 2019-12-13 Last updated: 2020-04-22

Open Access in DiVA

fulltext(1374 kB)34 downloads
File information
File name FULLTEXT01.pdfFile size 1374 kBChecksum SHA-512
ffb48d2fae7accb34eba1c498518ac9b2d061e3f8051cb1feb7cc902554d15552d42202d8aa6cd14b007bca3ed2cdc062e45f978581e8391b44b8fcfa2755899
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Authority records BETA

Huge, YlvaAbdul-Sattar Aljabery, Firas

Search in DiVA

By author/editor
Pelander, SofiaHuge, YlvaAbdul-Sattar Aljabery, Firas
By organisation
Department of Clinical and Experimental MedicineFaculty of Medicine and Health SciencesDepartment of Urology in Östergötland
In the same journal
International Urology and Nephrology
Urology and Nephrology

Search outside of DiVA

GoogleGoogle Scholar
Total: 34 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 38 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf